"Northeast Health Wangaratta (NHW) is a leading Victorian health service committed to providing quality health care to more than 90,000 people across North East Victoria. We are the major referral facility for people with complex health needs from Bright, Mansfield, Beechworth, Myrtleford, Yarrawonga, Euroa and Benalla. We also provide a telehealth service to these smaller facilities, allowing doctors at Northeast Health to provide medical advice via video link. Our hospital has a 24/7 Emergency Department and offers an extensive range of healthcare services as well as our residential aged care facility, Illoura."

During the past decade, Northeast Health Wangaratta conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Health Wangaratta" #1 collaborator was "Australian and New Zealand College of Anaesthetists" with 1 trials as a collaborator, "National Health and Medical Research Council, Australia" with 1 trials as a collaborator and "Victorian Comprehensive Cancer Centre" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Health Wangaratta" are "Colonic Cancer" (1 trials), "Dementia" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Rectal Cancer" (1 trials). Many other conditions were trialed in "Northeast Health Wangaratta" in a lesser frequency.

Most popular intervention types in "Northeast Health Wangaratta" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lidocaine IV" (1 trials), "Oral Fasudil 180 mg/day" (1 trials), "Oral Fasudil 90 mg/day" (1 trials), "Oral Placebo" (1 trials) and "Propofol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Health Wangaratta" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Northeast Health Wangaratta". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Northeast Health Wangaratta, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Health Wangaratta, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".